Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on ...

Johnson & Johnson (J&J) has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

A RECENT study has highlighted key biological and clinical factors linked to resistance to biologic therapies in patients ...

Art Garfunkel, 83, talks exclusively with PEOPLE about taking a step back from his career to prioritize his health amid his ...

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

In individuals with psoriasis, the immune system malfunctions, causing inflammatory cells to accumulate in the dermis, the ...

In the Phase III ICONIC-LEAD trial, 75% of adolescents with moderate-to-severe plaque psoriasis treated with icotrokinra ...

If you’re experiencing a flaking, itching scalp, you may do a quick self-diagnosis of dandruff. But that flaking and itching ...

Ultrasound-detected dactylitis lesions may help identify patients with psoriasis who are at risk for psoriatic arthritis and ...

Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...